238 related articles for article (PubMed ID: 31640103)
1. Plasma Neurofilament Light Chain in Primary Progressive Aphasia and Related Disorders: Clinical Significance and Metabolic Correlates.
Matías-Guiu JA; Gómez-Pinedo U; Forero L; Pytel V; Cano F; Moreno-Ramos T; Cabrera-Martín MN; Matías-Guiu J; González-Rosa JJ
J Alzheimers Dis; 2019; 72(3):773-782. PubMed ID: 31640103
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
5. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.
Steinacker P; Semler E; Anderl-Straub S; Diehl-Schmid J; Schroeter ML; Uttner I; Foerstl H; Landwehrmeyer B; von Arnim CA; Kassubek J; Oeckl P; Huppertz HJ; Fassbender K; Fliessbach K; Prudlo J; Roßmeier C; Kornhuber J; Schneider A; Volk AE; Lauer M; Danek A; Ludolph AC; Otto M;
Neurology; 2017 Mar; 88(10):961-969. PubMed ID: 28179468
[TBL] [Abstract][Full Text] [Related]
7. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
8. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
[TBL] [Abstract][Full Text] [Related]
9. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
[TBL] [Abstract][Full Text] [Related]
10. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
11. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
12. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.
Paraskevas GP; Kasselimis D; Kourtidou E; Constantinides V; Bougea A; Potagas C; Evdokimidis I; Kapaki E
J Alzheimers Dis; 2017; 55(4):1453-1461. PubMed ID: 27858708
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of serum NfL and p-Tau
Benussi A; Karikari TK; Ashton N; Gazzina S; Premi E; Benussi L; Ghidoni R; Rodriguez JL; Emeršič A; Simrén J; Binetti G; Fostinelli S; Giunta M; Gasparotti R; Zetterberg H; Blennow K; Borroni B
J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):960-967. PubMed ID: 32611664
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
16. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
17. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
[TBL] [Abstract][Full Text] [Related]
18. Dual-phase
Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
[TBL] [Abstract][Full Text] [Related]
20. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
Lewczuk P; Ermann N; Andreasson U; Schultheis C; Podhorna J; Spitzer P; Maler JM; Kornhuber J; Blennow K; Zetterberg H
Alzheimers Res Ther; 2018 Jul; 10(1):71. PubMed ID: 30055655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
